Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Gene | KIT |
| Variant | I571_D579dup |
| Impact List | duplication |
| Protein Effect | unknown |
| Gene Variant Descriptions | KIT I571_D579dup (also referred to as D579_H580insIDPTQLPYD) indicates the insertion of nine duplicate amino acids, isoleucine (I)-571 through aspartic acid (D)-579, in the juxtamembrane domain (exon 11) of the Kit protein (PMID: 16226710). I571_D579dup has been identified in sequencing studies (PMID: 19768731, PMID: 23291969), but has not been biochemically characterized and therefore, its effect on Kit protein function is unknown (PubMed, Nov 2025). |
| Associated Drug Resistance | |
| Category Variants Paths |
KIT mutant KIT exon11 KIT I571_D579dup |
| Transcript | NM_000222.3 |
| gDNA | chr4:g.54727479_54727505 |
| cDNA | c.1711_1737 |
| Protein | p.I571_D579 |
| Source Database | RefSeq |
| Genome Build | GRCh38/hg38 |
| Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
|---|---|---|---|---|---|
| NM_000222 | chr4:g.54727479_54727505 | c.1711_1737 | p.I571_D579 | RefSeq | GRCh38/hg38 |
| XM_017008178 | chr4:g.54727479_54727505 | c.1711_1737 | p.I571_D579 | RefSeq | GRCh38/hg38 |
| NM_000222.3 | chr4:g.54727479_54727505 | c.1711_1737 | p.I571_D579 | RefSeq | GRCh38/hg38 |
| XM_017008178.1 | chr4:g.54727479_54727505 | c.1711_1737 | p.I571_D579 | RefSeq | GRCh38/hg38 |
| NM_001385285.1 | chr4:g.54727479_54727505 | c.1711_1737 | p.I571_D579 | RefSeq | GRCh38/hg38 |
| NM_000222.2 | chr4:g.54727479_54727505 | c.1711_1737 | p.I571_D579 | RefSeq | GRCh38/hg38 |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|---|---|---|---|---|---|---|
| KIT I571_D579dup | Advanced Solid Tumor | predicted - resistant | Sunitinib | Preclinical - Cell culture | Actionable | In a preclinical study, transformed cells expressing KIT I571_D579dup (KIT D579_H580insIDPTQLPYD) were moderately resistant to Sutent (sunitinib) in culture (PMID: 24205792). | 24205792 |
| KIT I571_D579dup | Advanced Solid Tumor | predicted - resistant | Imatinib | Preclinical - Cell culture | Actionable | In a preclinical study, transformed cells expressing KIT I571_D579dup (KIT D579_H580insIDPTQLPYD) were moderately resistant to Gleevec (imatinib) in culture (PMID: 24205792). | 24205792 |
| KIT I571_D579dup | Advanced Solid Tumor | predicted - resistant | Flumatinib | Preclinical - Cell culture | Actionable | In a preclinical study, transformed cells expressing KIT I571_D579dup (KIT D579_H580insIDPTQLPYD) were moderately resistant to Flumatinib in culture (PMID: 24205792). | 24205792 |